SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
Saved in:
| Title: | SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. |
|---|---|
| Authors: | McGovern BH; Seres Therapeutics, Cambridge, Massachusetts, USA., Ford CB; Seres Therapeutics, Cambridge, Massachusetts, USA., Henn MR; Seres Therapeutics, Cambridge, Massachusetts, USA., Pardi DS; Mayo Clinic, Gastroenterology Division, Rochester, Minnesota, USA., Khanna S; Mayo Clinic, Gastroenterology Division, Rochester, Minnesota, USA., Hohmann EL; Massachusetts General Hospital, Infectious Diseases Division, Boston, Massachusetts, USA., O'Brien EJ; Seres Therapeutics, Cambridge, Massachusetts, USA., Desjardins CA; Seres Therapeutics, Cambridge, Massachusetts, USA., Bernardo P; Seres Therapeutics, Cambridge, Massachusetts, USA., Wortman JR; Seres Therapeutics, Cambridge, Massachusetts, USA., Lombardo MJ; Seres Therapeutics, Cambridge, Massachusetts, USA., Litcofsky KD; Seres Therapeutics, Cambridge, Massachusetts, USA., Winkler JA; Seres Therapeutics, Cambridge, Massachusetts, USA., McChalicher CWJ; Seres Therapeutics, Cambridge, Massachusetts, USA., Li SS; Seres Therapeutics, Cambridge, Massachusetts, USA., Tomlinson AD; Seres Therapeutics, Cambridge, Massachusetts, USA., Nandakumar M; Seres Therapeutics, Cambridge, Massachusetts, USA., Cook DN; Seres Therapeutics, Cambridge, Massachusetts, USA., Pomerantz RJ; Seres Therapeutics, Cambridge, Massachusetts, USA., Auninš JG; Seres Therapeutics, Cambridge, Massachusetts, USA., Trucksis M; Seres Therapeutics, Cambridge, Massachusetts, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jun 15; Vol. 72 (12), pp. 2132-2140. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciaa387 |
